Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry
Clinical trial NCT04034121 · COMPLETED
Trial details
- NCT number
- NCT04034121
- Sponsor
- Elixir Medical Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-20
- Primary completion
- 2017-01-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.